Clinical Trial Update: BEtablocker Treatment After Acute Myocardial Infarction in Patients Without Reduced Left Ventricular Systolic Function [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on BEtablocker as treatment after acute myocardial infarction in patients without reduced left ventricular function. The study is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction
• Non-st-elevation Myocardial Infarction
• St-elevation Myocardial Infarction

Drugs mentioned

• BEtablocker (beta-adrenergic receptor blocker)

Snippet

Sponsor: Oslo University Hospital | Conditions: Acute Myocardial Infarction, Non-ST Elevation Myocardial Infarction | Phase 4 | Status: ACTIVE_NOT_RECRUITING